ATE463493T1 - Als antipilzmittel geeignete azolderivate mit reduzierter wechselwirkung mit metabolischen zytochromen - Google Patents
Als antipilzmittel geeignete azolderivate mit reduzierter wechselwirkung mit metabolischen zytochromenInfo
- Publication number
- ATE463493T1 ATE463493T1 AT04790506T AT04790506T ATE463493T1 AT E463493 T1 ATE463493 T1 AT E463493T1 AT 04790506 T AT04790506 T AT 04790506T AT 04790506 T AT04790506 T AT 04790506T AT E463493 T1 ATE463493 T1 AT E463493T1
- Authority
- AT
- Austria
- Prior art keywords
- cytochromes
- metabolic
- fungal agent
- azole derivatives
- derivatives suitable
- Prior art date
Links
- 229940121375 antifungal agent Drugs 0.000 title abstract 2
- 239000003429 antifungal agent Substances 0.000 title abstract 2
- 102000018832 Cytochromes Human genes 0.000 title 1
- 108010052832 Cytochromes Proteins 0.000 title 1
- 150000007980 azole derivatives Chemical class 0.000 title 1
- 230000003993 interaction Effects 0.000 title 1
- 230000002503 metabolic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 125000000815 N-oxide group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002020A ITMI20032020A1 (it) | 2003-10-17 | 2003-10-17 | Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici |
| PCT/EP2004/011667 WO2005040156A1 (en) | 2003-10-17 | 2004-10-14 | Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE463493T1 true ATE463493T1 (de) | 2010-04-15 |
Family
ID=34509451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04790506T ATE463493T1 (de) | 2003-10-17 | 2004-10-14 | Als antipilzmittel geeignete azolderivate mit reduzierter wechselwirkung mit metabolischen zytochromen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7427620B2 (de) |
| EP (1) | EP1673368B1 (de) |
| JP (1) | JP4744446B2 (de) |
| KR (1) | KR101182740B1 (de) |
| CN (1) | CN1867565B (de) |
| AT (1) | ATE463493T1 (de) |
| BR (1) | BRPI0415319A (de) |
| CA (1) | CA2542361C (de) |
| CY (1) | CY1112166T1 (de) |
| DE (1) | DE602004026457D1 (de) |
| DK (1) | DK1673368T3 (de) |
| ES (1) | ES2344703T3 (de) |
| IT (1) | ITMI20032020A1 (de) |
| PL (1) | PL1673368T3 (de) |
| PT (1) | PT1673368E (de) |
| SI (1) | SI1673368T1 (de) |
| WO (1) | WO2005040156A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5963363B2 (ja) | 2010-09-30 | 2016-08-03 | 国立大学法人 鹿児島大学 | Auroraキナーゼプロモーターを含む増殖制御型ウイルスベクター |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3609596A1 (de) * | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
| EP0237693A1 (de) | 1986-03-21 | 1987-09-23 | Ambrogio Catracchia | Düse zum Reinigen von Zähnen und zahnärztlichen Apparaten |
| US4788190A (en) * | 1986-12-24 | 1988-11-29 | Schering Corporation | 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds |
| ZA9410142B (en) | 1993-12-21 | 1996-05-02 | Schering Corp | Tetrahydrofuran antifungals |
| AU3483497A (en) | 1996-06-28 | 1998-01-21 | Schering Corporation | Solid solution of an antifungal agent with enhanced bioavailability |
| EE03876B1 (et) | 1997-02-11 | 2002-10-15 | Janssen Pharmaceutica N.V. | Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid |
| EP0957101A1 (de) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Wasserlösliche Azole als Breitspektrum-antifungus |
| FR2807434B1 (fr) * | 2000-04-05 | 2002-10-18 | Hoechst Marion Roussel Inc | Nouveaux derives de la 1,2,3,4-tetrahydroisoquinoleine, leur procede de preparation et leur application comme fongicides |
-
2003
- 2003-10-17 IT IT002020A patent/ITMI20032020A1/it unknown
-
2004
- 2004-10-14 CN CN2004800306079A patent/CN1867565B/zh not_active Expired - Fee Related
- 2004-10-14 EP EP04790506A patent/EP1673368B1/de not_active Expired - Lifetime
- 2004-10-14 PL PL04790506T patent/PL1673368T3/pl unknown
- 2004-10-14 DK DK04790506.2T patent/DK1673368T3/da active
- 2004-10-14 AT AT04790506T patent/ATE463493T1/de active
- 2004-10-14 JP JP2006534715A patent/JP4744446B2/ja not_active Expired - Fee Related
- 2004-10-14 CA CA2542361A patent/CA2542361C/en not_active Expired - Fee Related
- 2004-10-14 SI SI200431440T patent/SI1673368T1/sl unknown
- 2004-10-14 DE DE602004026457T patent/DE602004026457D1/de not_active Expired - Lifetime
- 2004-10-14 WO PCT/EP2004/011667 patent/WO2005040156A1/en not_active Ceased
- 2004-10-14 BR BRPI0415319-7A patent/BRPI0415319A/pt not_active Application Discontinuation
- 2004-10-14 US US10/576,194 patent/US7427620B2/en not_active Expired - Fee Related
- 2004-10-14 PT PT04790506T patent/PT1673368E/pt unknown
- 2004-10-14 ES ES04790506T patent/ES2344703T3/es not_active Expired - Lifetime
- 2004-10-14 KR KR1020067007093A patent/KR101182740B1/ko not_active Expired - Fee Related
-
2010
- 2010-06-11 CY CY20101100539T patent/CY1112166T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20032020A1 (it) | 2005-04-18 |
| EP1673368B1 (de) | 2010-04-07 |
| CN1867565B (zh) | 2011-06-22 |
| BRPI0415319A (pt) | 2006-12-05 |
| CY1112166T1 (el) | 2015-12-09 |
| WO2005040156A8 (en) | 2005-06-23 |
| JP4744446B2 (ja) | 2011-08-10 |
| KR20060130554A (ko) | 2006-12-19 |
| ES2344703T3 (es) | 2010-09-03 |
| PT1673368E (pt) | 2010-07-09 |
| US7427620B2 (en) | 2008-09-23 |
| PL1673368T3 (pl) | 2010-09-30 |
| CA2542361C (en) | 2012-04-24 |
| DE602004026457D1 (de) | 2010-05-20 |
| DK1673368T3 (da) | 2010-06-07 |
| JP2007533638A (ja) | 2007-11-22 |
| WO2005040156A1 (en) | 2005-05-06 |
| CN1867565A (zh) | 2006-11-22 |
| US20070129376A1 (en) | 2007-06-07 |
| KR101182740B1 (ko) | 2012-09-13 |
| EP1673368A1 (de) | 2006-06-28 |
| CA2542361A1 (en) | 2005-05-06 |
| SI1673368T1 (sl) | 2010-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20220155A1 (ar) | مشتقات البيرازول مفيدة كعوامل مضادة للسرطان | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| MX2009008540A (es) | Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina. | |
| NO20073743L (no) | Forbindelser med Kv4 ionekanal aktivitet | |
| NO20066055L (no) | Pyridinderivater | |
| NO20080399L (no) | Farmasoytiske sammensetninger for forlenget avgivelse, samt fremgangsmater for fremstilling derav | |
| NO20073357L (no) | 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien | |
| PA8591701A1 (es) | Derivados de pirrolopirimidina | |
| NO20085087L (no) | Nye heterocykliske forbindelser | |
| DOP2009000124A (es) | Derivados de benzamida como receptores agonista ep4 | |
| AR066972A1 (es) | Derivados azapeptidicos | |
| SE0400284D0 (sv) | Novel compounds | |
| UA89040C2 (ru) | Замещенные глюкопиранозилом бензольные производные, лекарственное средство, которое содержит эти соединения | |
| TW200643013A (en) | Pyrazoles | |
| NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| ATE455103T1 (de) | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
| NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| NO20064705L (no) | Nye farmasoytiske preparater omfattende agonister av tyroidreseptoren | |
| MX2022000598A (es) | Preparacion de compuestos antibacterianos. | |
| CL2003002565A1 (es) | Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci | |
| ATE490958T1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
| SE0401655D0 (sv) | New compounds | |
| CO2023000854A2 (es) | Nuevo derivado de pirazol | |
| TW200740795A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1673368 Country of ref document: EP |